Waters Corporation $WAT Shares Purchased by NewEdge Advisors LLC

NewEdge Advisors LLC raised its stake in shares of Waters Corporation (NYSE:WAT) by 10,340.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,654 shares of the medical instruments supplier’s stock after acquiring an additional 3,619 shares during the quarter. NewEdge Advisors LLC’s holdings in Waters were worth $1,088,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC lifted its position in shares of Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC increased its holdings in Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after buying an additional 30 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Waters by 3.6% in the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after buying an additional 6,976 shares during the last quarter. Empowered Funds LLC raised its stake in Waters by 16.6% during the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after buying an additional 160 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in Waters during the 2nd quarter worth approximately $232,000. Institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling at Waters

In other news, Director Christopher A. Kuebler sold 3,626 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

WAT has been the subject of several research reports. Evercore reiterated an “outperform” rating and issued a $420.00 target price on shares of Waters in a research report on Wednesday, August 5th. Royal Bank Of Canada upped their price target on Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $400.00 price objective on shares of Waters in a report on Wednesday, August 5th. Stifel Nicolaus set a $420.00 target price on shares of Waters in a research note on Wednesday, August 5th. Finally, TD Cowen upgraded shares of Waters from a “hold” rating to a “buy” rating and boosted their target price for the company from $408.00 to $475.00 in a research note on Wednesday, August 5th. Three research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Waters presently has an average rating of “Moderate Buy” and an average target price of $420.35.

Waters Price Performance

NYSE WAT opened at $407.75 on Tuesday. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $420.26. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. The stock has a market cap of $40.06 billion, a price-to-earnings ratio of 101.68, a price-to-earnings-growth ratio of 2.40 and a beta of 1.19. The company has a 50-day moving average price of $378.07 and a two-hundred day moving average price of $346.12.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, beating analysts’ consensus estimates of $3.01 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The business’s revenue for the quarter was up 113.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Analysts forecast that Waters Corporation will post 14.57 EPS for the current year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.